In April 2015, Cold Spring Harbor Laboratory entered into a strategic affiliation with Northwell Health. The alliance provides CSHL’s basic cancer researchers with access to Northwell’s growing network of clinical services encompassing more than 19,000 new cancer cases annually across the metropolitan area.
The Southwest Oncology Group (SWOG) is part of the largest cancer research group in the nation, leading clinical trials as an integral part of the NCI National Cancer Trials Network. The CSHL Cancer Center has been an active member of SWOG since 2011, and CSHL Cancer Center members are invited to attend biannual SWOG meetings.
NCI Integrated Translational Science Center
In collaboration with SWOG and The Jackson Laboratory (JAX), CSHL has established an NCI Integrated Translational Science Center (ITSC). This ITSC brings together two elite cancer research programs with a leading clinical cancer research network. CSHL and JAX, both NCI-designated Cancer Centers, have significant collective expertise in the genetics and functional genomics of cancer, and have joined forces with SWOG, an NCI-funded cancer clinical trials cooperative group and a member of the National Cancer Trials Network. The partnership provides an unprecedented collaboration with great potential to improve outcomes in patients with cancer.
The CSHL-JAX-SWOG ITSC is focused on advancing genome science and patient-derived models to rapidly develop novel therapeutics, optimize combinatorial treatments, and identify powerful biomarkers for precision cancer medicine. Funded by U10CA180944 from the NCI and by The Hope Foundation, the ITSC support pilot projects that represent true partnerships between SWOG investigators and co-PIs from CSHL or JAX. The ITSC also hosts an annual Translation Workshop to train young oncologists and lab investigators, and foster interaction between basic scientists and clinical researchers.